Cargando…

Development of bullous lung disease with pneumothorax following SARS‐CoV‐2 infection

Cystic lung formation secondary to severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection was described during coronavirus disease pandemic, but with relatively low prevalence. A rare yet under‐recognized complication is that these cystic areas may progress to bullae, cavities and pn...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdullah, Hafizah, Wong, Yen Shen, Ibrahim, Muhammad Amin, Natasya Musa, Aisya, Jayaraman, Thevaraajan, Mohd Zim, Mohd Arif
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9344262/
https://www.ncbi.nlm.nih.gov/pubmed/35928243
http://dx.doi.org/10.1002/rcr2.1013
_version_ 1784761182110875648
author Abdullah, Hafizah
Wong, Yen Shen
Ibrahim, Muhammad Amin
Natasya Musa, Aisya
Jayaraman, Thevaraajan
Mohd Zim, Mohd Arif
author_facet Abdullah, Hafizah
Wong, Yen Shen
Ibrahim, Muhammad Amin
Natasya Musa, Aisya
Jayaraman, Thevaraajan
Mohd Zim, Mohd Arif
author_sort Abdullah, Hafizah
collection PubMed
description Cystic lung formation secondary to severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection was described during coronavirus disease pandemic, but with relatively low prevalence. A rare yet under‐recognized complication is that these cystic areas may progress to bullae, cavities and pneumothorax. We reported two cases of ruptured bullae with pneumothorax following SARS‐CoV‐2 infection. Two patients were discharged following SARS‐CoV‐2 pneumonia, which did not require invasive mechanical ventilation (IMV). However, both patients presented again a month later with shortness of breath. Repeated computed tomography (CT) thorax showed development of bullous lung disease and pneumothorax. The first patient underwent surgical intervention whilst the second patient was treated conservatively. Development of bullous lung disease following SARS‐CoV‐2 infection is rare but may be associated with serious morbidity. Patients whose general condition permits should be offered surgical intervention whilst conservative management is reserved for non‐surgical candidates.
format Online
Article
Text
id pubmed-9344262
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley & Sons, Ltd
record_format MEDLINE/PubMed
spelling pubmed-93442622022-08-03 Development of bullous lung disease with pneumothorax following SARS‐CoV‐2 infection Abdullah, Hafizah Wong, Yen Shen Ibrahim, Muhammad Amin Natasya Musa, Aisya Jayaraman, Thevaraajan Mohd Zim, Mohd Arif Respirol Case Rep Case Reports Cystic lung formation secondary to severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection was described during coronavirus disease pandemic, but with relatively low prevalence. A rare yet under‐recognized complication is that these cystic areas may progress to bullae, cavities and pneumothorax. We reported two cases of ruptured bullae with pneumothorax following SARS‐CoV‐2 infection. Two patients were discharged following SARS‐CoV‐2 pneumonia, which did not require invasive mechanical ventilation (IMV). However, both patients presented again a month later with shortness of breath. Repeated computed tomography (CT) thorax showed development of bullous lung disease and pneumothorax. The first patient underwent surgical intervention whilst the second patient was treated conservatively. Development of bullous lung disease following SARS‐CoV‐2 infection is rare but may be associated with serious morbidity. Patients whose general condition permits should be offered surgical intervention whilst conservative management is reserved for non‐surgical candidates. John Wiley & Sons, Ltd 2022-08-02 /pmc/articles/PMC9344262/ /pubmed/35928243 http://dx.doi.org/10.1002/rcr2.1013 Text en © 2022 The Authors. Respirology Case Reports published by John Wiley & Sons Australia, Ltd on behalf of The Asian Pacific Society of Respirology. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Abdullah, Hafizah
Wong, Yen Shen
Ibrahim, Muhammad Amin
Natasya Musa, Aisya
Jayaraman, Thevaraajan
Mohd Zim, Mohd Arif
Development of bullous lung disease with pneumothorax following SARS‐CoV‐2 infection
title Development of bullous lung disease with pneumothorax following SARS‐CoV‐2 infection
title_full Development of bullous lung disease with pneumothorax following SARS‐CoV‐2 infection
title_fullStr Development of bullous lung disease with pneumothorax following SARS‐CoV‐2 infection
title_full_unstemmed Development of bullous lung disease with pneumothorax following SARS‐CoV‐2 infection
title_short Development of bullous lung disease with pneumothorax following SARS‐CoV‐2 infection
title_sort development of bullous lung disease with pneumothorax following sars‐cov‐2 infection
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9344262/
https://www.ncbi.nlm.nih.gov/pubmed/35928243
http://dx.doi.org/10.1002/rcr2.1013
work_keys_str_mv AT abdullahhafizah developmentofbullouslungdiseasewithpneumothoraxfollowingsarscov2infection
AT wongyenshen developmentofbullouslungdiseasewithpneumothoraxfollowingsarscov2infection
AT ibrahimmuhammadamin developmentofbullouslungdiseasewithpneumothoraxfollowingsarscov2infection
AT natasyamusaaisya developmentofbullouslungdiseasewithpneumothoraxfollowingsarscov2infection
AT jayaramanthevaraajan developmentofbullouslungdiseasewithpneumothoraxfollowingsarscov2infection
AT mohdzimmohdarif developmentofbullouslungdiseasewithpneumothoraxfollowingsarscov2infection